This article provides key insights and suggested best practices for managed care to improve patient care in MPS disorders, which may also be relevant to other rare and ultra-rare conditions.
Issue Brief - Main Street Pharmacy Access Act
AMCP Supports the Main Street Pharmacy Act
AMCP supports the Main Street Pharmacy Act. This bill will help ensure that Americans can continue to rely on pharmacists as essential partners in pandemic preparedness and response. The Act will also improve patient access to tests and treatments by authorizing pharmacists to provide these services and receive reimbursement under Medicare Part B. The Act addresses disparities in public health preparedness in medically underserved communities like rural areas by allowing these patients to seek care from their most accessible provider.
AMCP calls on Members of Congress to cosponsor and ultimately enact the Main Street Pharmacy Act (H.R. 3164 / S. 2426), which will preserve access to essential care administered by pharmacists and increase the country's readiness for future public health emergencies.
Related
As part of a multi-year RWE initiative, AMCP Research Institute partnered with IQVIA, payers, pharmaceutical companies, and others to design payer-focused RWE standards that were published in JMCP in September, 2025.
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
